Bio-Connect

c-Rel antibody [N1N3]

GTX113264
GeneTex
ApplicationsImmunoPrecipitation, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetREL
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    c-Rel antibody [N1N3]
  • Delivery Days Customer
    9
  • Application Supplier Note
    IHC-P: 1:100-1:1000. IP: 1:100-1:500. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoPrecipitation, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID5966
  • Target name
    REL
  • Target description
    REL proto-oncogene, NF-kB subunit
  • Target synonyms
    C-Rel; HIVEN86A; oncogene REL, avian reticuloendotheliosis; proto-oncogene c-Rel; v-rel avian reticuloendotheliosis viral oncogene homolog
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDQ04864
  • Protein Name
    Proto-oncogene c-Rel
  • Scientific Description
    The REL gene encodes c-Rel, a transcription factor that is a member of the Rel/NFKB family, which also includes RELA (MIM 164014), RELB (604758), NFKB1 (MIM 164011), and NFKB2 (MIM 164012). These proteins are related through a highly conserved N-terminal region termed the Rel domain, which is responsible for DNA binding, dimerization, nuclear localization, and binding to the NFKB inhibitor (MIM 164008) (Belguise and Sonenshein, 2007 [PubMed 18037997]).[supplied by OMIM]
  • Reactivity
    Human
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Phosphorylation of NF-kappaBp65 drives inflammation-mediated hepatocellular carcinogenesis and is a novel therapeutic target. Xu X et al., 2021 Aug 11, J Exp Clin Cancer Res
    Read more
  • Identification of a Selective RelA Inhibitor Based on DSE-FRET Screening Methods. Shiroma Y et al., 2020 Nov 30, Int J Mol Sci
    Read more